Herald Investment Trust PLC
14 February 2002
Herald Investment Trust plc
Appointment of New Director
The Board is pleased to announce that Mr Douglas McDougall OBE was appointed a
Director of Herald Investment Trust plc on 13 February 2002, his appointment
falls to be ratified by Shareholders at the Company's Annual General Meeting in
April 2002.
Douglas McDougall aged 57, was a partner of Baillie Gifford & Co. from 1969
until April 1999. From 1989, when he was appointed joint senior partner, until
his retirement in 1999, he was in overall charge both of the firm's investment
departments and of its investment policy committee. He is chairman of the Law
Debenture Corporation plc, The Independent Investment Trust Plc, Foreign &
Colonial Eurotrust plc and 3i Bioscience Investment Trust plc. He is a former
chairman of IMRO, of the Association of Investment Trust Companies and of the
Fund Managers' Association.
Baillie Gifford & Co.
Company Secretaries
14 February 2002
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.